December 4, 2022
Loading...
You are here:  Home  >  middle  >  Current Article

Amgen pilots new drug strategy after investing in T.O. campus

IN THIS ARTICLE

Some employees have new work spaces after Amgen spent $200 million renovating and upgrading its Thousand Oaks campus. (Marissa Nall photo)   Investments at its flagship facilities in Thousand Oaks mark a strategic shift for Amgen when it comes to choosing which diseases the biotech giant tackles. With the infusion of $200 million in capital,…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.